Abirakast 250mg Tablet
Abirakast 250mg Tablet
Abirakast 250mg Tablet
Abirakast 250mg Tablet

Abirakast 250mg Tablet

Price 4800.0 INR/ Bottle

MOQ : 10 Bottles

Abirakast 250mg Tablet Specification

  • Indication
  • Prostate Cancer
  • Dosage Form
  • Tablet
  • Origin
  • India
  • Salt Composition
  • Abiraterone Acetate 250mg
  • Enzyme Types
  • Other
  • Feature
  • Other
  • Ingredients
  • Other
  • Application
  • Other
  • Physical Color/Texture
  • Other
  • Storage Instructions
  • Store below 30C in a dry place
  • Shelf Life
  • 24 Months
  • Trade Name
  • Abirakast
  • Strength
  • 250 mg
  • Availability
  • Export quality, prescription only
  • Prescription Required
  • Yes
  • Administration Route
  • Oral
  • Brand Name
  • Abirakast 250mg Tablet
  • Storage Condition
  • Keep away from light and moisture
  • Patient Age Group
  • Adult Men
  • Packaging
  • 120 tablets per bottle
  • Regulatory Status
  • Prescription Drug
 

Abirakast 250mg Tablet Trade Information

  • Minimum Order Quantity
  • 10 Bottles
  • Supply Ability
  • 500 Bottles Per Month
  • Delivery Time
  • 7 Days
  • Main Domestic Market
  • All India
 

Abirakast 250mg Tablet About



Abirakast 250mg Tablet is a highly recommended and rare solution for advanced prostate cancer, boasting brilliant efficacy as a potent CYP17 inhibitor. Magnificently crafted for export quality, it procures superior results by inhibiting androgen biosynthesis. Each bottle contains 120 white to off-white film-coated tablets, administered orally and specifically formulated for adult men. This prescription-required medication aligns with lofty international standards and delivers consistent performance. Abirakast is odorless and should be stored away from light and moisture at temperatures below 30C, ensuring a remarkable shelf life of 24 months.

Why Choose Abirakast 250mg Tablet?

Abirakast 250mg Tablet is favored for its primary competitive advantage: potent CYP17 enzyme inhibition, delivering effective management of advanced prostate cancer. Suitable for adult men, it is administered orally, ensuring ease of use and precise dosage control. Crafted for reliable performance, Abirakast's export-quality formulation stands out among alternatives for its efficacy, safety, and compliance with international regulations, making it a preferred choice for oncology specialists.


Export, Delivery, and Freight Details for Abirakast 250mg Tablet

Abirakast 250mg Tablet ships from India's prominent FOB ports, supplied globally to main export markets across Asia, Africa, the Middle East, and Latin America. Exporters and suppliers maintain transparent sample policies and reliable freight options, ensuring products are delivered promptly and securely. Comprehensive support simplifies the delivery process, meeting various regulatory requirements and assuring customers of consistent availability and efficient shipment worldwide.

Export Information

  • Worldwide Export Available
  • Air Cargo & Courier Shipping
  • Export Documentation Support
  • Bulk Orders Accepted
  • Hospital, Pharmacy & Distributor Supply
  • Competitive Pricing 

FAQ's of Abirakast 250mg Tablet:


Q: How should Abirakast 250mg Tablet be administered?

A: Abirakast 250mg Tablet is taken orally, typically as directed by a healthcare provider specializing in oncology. It is important to follow the prescribed dosage and administration schedule to achieve optimal therapeutic results.

Q: What are the storage conditions required for Abirakast 250mg Tablet?

A: The tablets should be stored below 30C in a dry place, away from light and moisture, as improper storage may affect their quality and efficacy.

Q: When is Abirakast 250mg Tablet indicated for use in patients?

A: Abirakast 250mg Tablet is indicated for adult men diagnosed with advanced prostate cancer, particularly when traditional therapies are no longer effective.

Q: Where can Abirakast 250mg Tablet be sourced or procured?

A: Abirakast 250mg Tablet is available through authorized exporters, suppliers, traders, and wholesalers in India, strictly on a prescription-only basis for international and domestic markets.

Q: What is the benefit of Abirakast's CYP17 inhibition in prostate cancer therapy?

A: By inhibiting the CYP17 enzyme, Abirakast reduces androgen production, which plays a significant role in the progression of advanced prostate cancer, thereby supporting improved patient outcomes as part of comprehensive cancer management.

Q: How can I obtain a quotation?

A:  Please share the required quantity, destination country, and consignee details. We will provide our best quotation along with delivery timelines and shipping options.

Tell us about your requirement
product

Price:  

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Oncology Tablets Category

Abiraterone Acetate 500 mg

Abiraterone Acetate 500 mg

Price 8999.0 INR

Minimum Order Quantity : 60 Pieces

Dosage Form : orally

Origin : india

Feature : Other

Ingredients : Other

Darbepoetin alfa injection

Darbepoetin alfa injection

Price 2900.0 INR / Number

Minimum Order Quantity : 10

Dosage Form : liquid

Origin : india

Feature : Other

Ingredients : Other

Arbitus 250mg Tablet

Arbitus 250mg Tablet

Price 11000.0 INR / Bottle

Minimum Order Quantity : 1 Bottle

Dosage Form : Tablet

Origin : Indian

Feature : Other

Ingredients : Other



Back to top